NeuroCog Trials provides global support for precise neurocognitive data collection in clinical trials. With gold standard instruments, innovative technology and highly personalized services, the company provides expertise in measurement, interpretation, reporting, and data quality assurance for accurately defining the effects of various treatments on cognition.
Click here to download fact sheet.
Richard S.E. Keefe, PhD, Chief Executive Officer
For over 25 years, Dr. Keefe has focused on the assessment and treatment of neurocognitive impairment in schizophrenia, Alzheimer’s disease, and other psychiatric and neurologic disorders. Dr. Keefe is also Professor of Psychiatry, Psychology, and Neurosciences at Duke University Medical Center.
Caren Gadigan, President
Ms. Gadigian is the president and co-founder of NeuroCog Trials. She brings extensive knowledge of finance and business from over 20 years of working with private investment firms. During her 12+ years at NeuroCog Trials, Ms. Gadigian has spearheaded the organization’s strategic growth and global expansion of services.
NeuroCog Trials website: www.neurocogtrials.com
For more information or to further discuss your study needs please contact: